Jo-Anne H Young – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailvanbu004umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

17 Active
54 Finished

17 results

Filter

Active
A Phase III, adjudicator-blinded, randomised study toevaluate the efficacy and safety of treatment with olorofimversus treatment with AmBisome? followed by standard ofcare (SOC) in patients with invasive fungal disease (IFD)caused by Aspergillus spec
Young, J. H.
F2G LTD
1/19/23 → 1/31/28
Project: Research project
A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added to systemic antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis
Young, J. H.
PULMOCIDE, LTD
9/22/22 → 9/30/27
Project: Research project
A Phase3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or InvasiveCandidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Intravenous Echinocandin followed by OralFluconazole
Young, J. H.
SCYNEXIS, INC.
7/14/22 → 7/31/27
Project: Research project
Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)
Young, J. H.
ALLOVIR, INC
3/23/22 → 6/30/28
Project: Research project
Phase 2 multicenter, randomized, double-blind, placebo-controlled, multiple dosing interval, 3-period studyof the safety, tolerability and effectiveness of adoptively transferred Viralym-M multivirus-specific T cells inkidney transplant recipients w
Young, J. H.
ALLOVIR, INC
4/28/21 → 11/30/25
Project: Research project
An Open-label, Single-arm Study of Letermovir (LTV) for Prevention of Recurrent CMV Infection in HighriskHematopoietic Cell Transplant (HCT) Recipients
Young, J. H.
MEMORIAL SLOAN-KETTERING CANCER CENTER, MERCK, SHARP & DOHME LLC
11/15/20 → 11/30/25
Project: Research project
Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M(ALVR-105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After AllogeneicHematopoietic Cell Transplant
Young, J. H.
ALLOVIR, INC
11/15/20 → 11/30/25
Project: Research project
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety andEfficacy of Viralym-M Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCVInfection and/or Disease, in High-Risk Patients After Al
Young, J. H.
ALLOVIR, INC
10/1/20 → 10/31/25
Project: Research project
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY, TOLERABILITY, AND EFFICACY OF RV521 IN THE TREATMENT OF ADULT SUBJECTS WHO HAVE UNDERGONE HEMATOPOIETIC CELL TRANSPLANTATION (HCT) WITH A DOCUMENTED UPPER RESPIRATORY TRACTINFECTION (URT)
Young, J. H.
REVIRAL LTD
6/24/20 → 1/31/24
Project: Research project
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney TransplantRecipients at High-Risk of Cytomegalovirus Infection, LionHeart21
Young, J. H.
NOBELPHARMA CO., LTD
6/12/20 → 6/30/25
Project: Research project
A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium(Clostridioides) Difficile Infection
Young, J. H.
VEDANTA BIOSCIENCES, INC
8/22/19 → 8/30/24
Project: Research project
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Tran
Young, J. H.
JANSSEN RESEARCH & DEVELOPMENT, LLC
7/31/19 → 7/31/24
Project: Research project
A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Combination Therapy of SCY-078 with Voriconazole in Patients with Invasive Pulmonary Aspergillosis (SCYNERGIA)
Young, J. H.
SCYNEXIS, INC.
3/29/19 → 3/30/24
Project: Research project
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for theTreatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Young, J. H.
ANSUN BIOPHARMA, INC
2/6/19 → 2/29/24
Project: Research project
A Multi-center, Retrospective Study of Serious Infections Caused by Acinetobacter baumanniicalcoaceticusComplex
Young, J. H.
ENTASIS THERAPEUTICS HOLDINGS INC
11/25/18 → 11/30/23
Project: Research project
Open-Label Study to Evaluate the Efficacy and Safety of
Young, J. H.
SCYNEXIS, INC.
11/1/16 → 6/30/24
Project: Research project
A Prospective Observational Study for the Long-term
Young, J. H.
CHIMERIX, INC.
11/5/14 → 11/4/24
Project: Research project